Article info

Download PDFPDF

Response to: ‘Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis’ by Wallace et al

Authors

  • Andreas Kronbichler Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK Department of Internal Medicine IV (Nephrology and Hypertension), Anichstraße, Innsbruck, Austria PubMed articlesGoogle scholar articles
  • Julia Kerschbaum Department of Internal Medicine IV (Nephrology and Hypertension), Anichstraße, Innsbruck, Austria PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Andreas Kronbichler, Department of Internal Medicine IV (Nephrology and Hypertension), Anichstraße, Innsbruck 6020, Austria; andreas.kronbichler{at}i-med.ac.at
View Full Text

Citation

Kronbichler A, Kerschbaum J
Response to: ‘Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis’ by Wallace et al

Publication history

  • Received January 10, 2019
  • Accepted January 11, 2019
  • First published January 30, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.